{
  "ticker": "LDX",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02969760",
  "id": "02969760",
  "pages": 2,
  "price_sensitive": false,
  "date": "20250716",
  "time": "1013",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250716/pdf/06lv8wyjzgtlbf.pdf",
  "summary": "**Summary of ASX Announcement (Investor Briefing Invitation):**  \n- **Key Event:** Webinar today (16 July 2025) to discuss recently announced **exclusive U.S. distribution agreement for FebriDx** with PHASE Scientific.  \n- **No material financial/operational data** disclosed in this announcement.  \n\n*Note: Pure event invitation; no immediate trading-impacting information.*",
  "usage": {
    "prompt_tokens": 783,
    "completion_tokens": 87,
    "total_tokens": 870,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-16T00:56:38.690355"
}